PTX 7.32% 4.4¢ prescient therapeutics limited

Ann: PTX receives New Patent on Companion Diagnostic for PTX-100, page-9

  1. 4,056 Posts.
    lightbulb Created with Sketch. 952

    Thanks, Patient. That's good news. I've just signed up.

    https://*.com.au/the-insider-2/

    PTX has a compelling story to tell. Hard to hear it and not be excited.

    I hope Steven Yatomi-Clarke will not simply reprise his September 9th Presenttion. I'm looking for pro-active management, and an energetic enterprise.

    In particuar, I'd like to hear the marketing plan for OmniCAR. We know we have a wonderful enabling technolgy - now ...who's being targeted, how is the sales strategy being advanced?

    We’ve got the opportunity to really light as many fires as possible, and collaborate and license this to third parties.

    ...we’ve got the opportunity here, a scalable business model, to add value in a lateral manner.

    So what's the plan?

    Do we need some early 'soft' collaborations for proof-of-concept? Or is this an easy bolt-on, the advantages and efficacy of which are already patently obvious to all in the field?

    We were also promised a strategic in-house review:

    ...to work out which indications, which programs, make sense for Prescient to undertake itself.


    With hints that ... it won’t just be one program.


    I'll be very happy to hear Steven articulating the Company's latest two months advance.



 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
4.4¢
Change
0.003(7.32%)
Mkt cap ! $35.43M
Open High Low Value Volume
4.1¢ 4.4¢ 4.0¢ $20.95K 507.0K

Buyers (Bids)

No. Vol. Price($)
8 216927 4.0¢
 

Sellers (Offers)

Price($) Vol. No.
4.4¢ 238807 2
View Market Depth
Last trade - 16.10pm 09/07/2024 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.